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ABSTRACT
Antimicrobial resistance is a major public health problem. In the Egyptian hospitals the problem
was discovered since 2006; however, seven years ago, this problem drew the attention to be one
of a major risk factors worldwide and in the Egyptian hospitals as well. International
organizations, such as World Health Organization (WHO) tried to find different solutions to
prevent transmission of these communicable diseases from country to another by setting different
guidelines and standards to be followed by countries. The case is to assess the barriers to
implementation of objectives and guidelines of WHO in one of the biggest public Egyptian
hospitals, in order to have enough knowledge and gather information about the current situation
in Egypt. In order to fulfill these objectives, case study from a large public hospital was
extensively studied through qualitative research methods including interviews and observational
studies. Findings of the current research are most relevant to public hospitals which serve a huge
sector in developing countries. Behavioral factors such as weak managerial support, lack of
communication between healthcare departments, absent standards and guidelines for diagnosis
and treatment, and subjective decisions in managing patients’ cases are among the major factors
contributing to the problem. Non behavioral factors such as inadequate infrastructure and poor
resources are also existing.
The results of the research give substantial contribution in understanding and identifying the
behavioral causes of prevalence of multidrug resistance (MDR) problem in Egypt and shed light
on the possible solutions.
Key words: WHO, behavioral aspect, antimicrobial policies, MDR.
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Chapter One: Introduction
Antimicrobials are medicines which eliminate different pathogens causing infections, such as
bacteria, viruses and parasites (Li et al, 2012). The nastiest microorganisms are the bacterial
infections which are treated by antimicrobials named antibiotics. Other antimicrobials which
combat viral and parasitic diseases, such as HIV and malaria are named antivirals and antiparasitic (World Health Organization, 2016). Since the first discovery of antibiotics, they have
saved millions of lives; this started 70 years ago (CDC, 2018).
Antimicrobial resistance (AMR) occurs when pathogens acquire new traits and new genes that
enable them to prevent the action of antimicrobials (CDC, 2019). Thus, People or animals who
are infected with resistant pathogens will suffer infections that are not responding to antibiotics.
Furthermore, the bacteria will be more aggressive; it will survive, and the patients get sicker and
may die (Tadesse et al, 2017). These resistant pathogens have the ability to transfer from one
patient to another; moreover, have the ability to transfer the resistance from one bacterium to
another; thus, the cost of medical care rises, and disease spreads nationally and internationally
(Santajit, 2016- Huddleston, 2014). AMR is on the rise and currently responsible for more than
700,000 deaths per year worldwide (Roca et al, 2015). According to the World Bank 2017
(http://www.worldbank.org/en/topic/health/publication/drug-resistant-infections-a-threat-to-oureconomic-future), if no strong measures are taken to prevent the progress, AMR will cost
approximately 10 million lives by 2050 worldwide in addition to about US$100 trillion per year
extra expenses which is more than cancer and diabetes burden combined (Scarafile, 2016).
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1.1 Antimicrobial resistance is a global problem
AMR is a global problem which require to apply the concept of “one health”; every country
irrespective of its level of income and development should be concerned about the problem as
resistant pathogens do not respect borders (Exner, 2017; WHO, 2016).
In recent decades, it is estimated that with every misuse of the antimicrobials either in the dosing,
frequency or timing, antimicrobial drugs are rapidly losing their effectiveness in both developing
and developed countries, and this foster the opportunity for AMR to flourish (Sefton, 2002).
However, rigorous management can limit the risks. As a result, people may face a reversal of the
public-health gains of the past century, and the economic growth if this trend continues (Allen,
2014). To contain the problem globally and nationally, the world health organization (WHO) set global
action plan (GAP) in 2015 with definite goals to be followed by countries. Each country should set its
strategic actions to fulfill the goals and ensure sustainability of actions (Mendelson et al, 2016).

1.2 RESEARCH OBJECTIVES
This research is intended to investigate the current behaviors and actions done by healthcare
workers which affect antimicrobial resistance and barriers to implementation of the global
action plan (GAP) in public hospitals in Egypt. Another aspect of the research is to understand
whether healthcare workers in Egypt are aware of the problem and of WHO international plans
for AMR. The research also will try to reach some characteristics of the needed reform and the
impeding factors.
1.3 Conceptual framework:
A conceptual framework definition is a chain of linked concepts which when analyzed it
offers the procedure required to build the frameworks based on the grounded theory
method (Jabareen, 2009). Analysis of conceptual framework has many benefits including
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its flexibility, capacity to modify and understanding instead of predicating (Jabareen,
2008).
Conceptual frameworks analysis offers the knowledge of know-how and plays
fundamental epistemological role to understand the difference between beliefs and facts. It
also explains the knowledge of the way things are in real existence. (Finney & Corbett,
2007).
Despite the importance and relation of pharmaceuticals with social and political science,
there has been a noticeable lack of input of social sciences in setting polices on how to use
the pharmaceuticals (Smith, 2015). This engagement represents the effective mean to
address the problem of AMR and to contain the risks of the problem (Cabral, 2015).
There is great trend to learn from the considerable work of social sciences, so as to provide
a collective and broader conceptual map through which effective strategies to tackle AMR
could be created (Cleary, 2016).
In this thesis the conceptual framework can be perceived by dividing the sectors of the
problem to private clinics which are managed by owners and depends on dispensing
antibiotics from pharmacies and pharmacies which are responsible for dispensing
antibiotics to the community. The second section is the public hospitals which are managed
by the government and its related departments including infection control and stewardship
departments. The two sectors are under the umbrella and existing in the community and are
affecting each other. This research will tackle the public hospitals part as it serves huge
sector in the community.
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Figure 1: Conceptual framework (WHO, 2006).
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1.4 RESEARCH QUESTIONS:
Based on the previous objectives, the research questions which are proposed could be formulated
as follows:


To what extent the WHO international policies of AMR are implemented in the
Egyptian hospitals? This question will examine the process, tools, monitoring and
evaluation used by healthcare workers to apply the standards of WHO.



Are health care workers aware of the problem? This question will give an idea about
the importance of the issue to healthcare workers.
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Are health care workers aware of the WHO policy for AMR? This will give an idea
about the effectiveness of WHO in local community and whether health care workers
know the WHO or not.



What prevent them from implementing the policy? This question will help to
understand the different barriers in different communities especially the behavioral
barriers.

1.5 Research outline
The present research is divided into five chapters. The first chapter contains the
introduction which gives a glance about the problem of antimicrobial resistance worldwide, role
of international organizations and countries to contain the problem. Research objectives, research
questions and conceptual framework are also presented in the introduction. Chapter two is the
literature review which tackles the problem and its health, economical and developmental
consequences; in addition, a detailed history of the emergence of the problem in Egypt starting
1999 till now and the actions that were taken in Egypt till now. The different qualitative
methodologies and SWOT analysis are clearly discussed in the third chapter. Chapter four gives
an analysis to the findings and discussion of the research. Finally, chapter five provides the
conclusion and recommendations of the study.
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Chapter Two: Literature Review
The literature review will cover the following six points in details
 The problem of Antimicrobial resistance
 The history of the problem
 The extent of the problem
 The consequences of Antimicrobial resistance on countries
 The status of Antimicrobial resistance in Egypt
 What should be done to face the problem?
 How the crisis is currently handled.
 The gap in the research that we will fulfill
2.1The problem of Antimicrobial resistance.
Antimicrobial resistance crises (AMR) is a grave threat to economy and health (Shrestha, 2018).
The excessive and faulty usage of antimicrobials in plants, animals, and human being, lead to
evolution of bacteria which is more aggressive and resistant. This phenomenon occurred
naturally from the continuous pressure of antibiotics (Shrestha, 2018).
Those infectious diseases become resistant to any known anti-microbial agent; moreover, they
are increasing in frequency and scope which will lead to detrimental consequences for the public
health (Marshall & Levy, 2011). This major crises was shaped by three main factors: the first one
is the fact that the bacteria are always changing evolutionary with different AMR phenotypes due
to the wide use of antibiotics (Spellberg et al, 2008) The second cause is that the world now has
no borders and the microbe can transfer from one community to another easily; the third and last
factor is the irrational and extensive use of antibiotics especially in developing countries where
there are no rules undermine over the counter consumption of antibiotics (Holmes et al, 2016).;
13

thus, this antibiotic selective pressure will eventually improve the evolution of bugs to AMR
ones. Some of these factors are amendable, others are not (Holmes et al, 2016). The fact that the
world become interconnected and open for all human being cannot be changed, but rules and
regulations can be put in place to reduce and prevent the evolution of bacteria by setting the
legislations and change behaviors for the rational use of antimicrobials in addition to extensive
education program to teach common people and healthcare workers (Michael, 2014).
Projections and speculations suggest that AMR will be a cause of public health crisis and
economic inequality globally which will mostly affect low and middle-income countries where
the burden of AMR is highest (Lim et al, 2016).
2.2 The history of the problem
Discovery of penicillin, the first antibiotic in the world, by Sir Alexander Fleming in 1928 is
considered the start of modern era of antibiotics (Sengupta et al, 2013). Penicillin transformed
the modern medicine and saved millions of people worldwide (Gould & Bal, 2013).
In 1940 antibiotics were prescribed for the first time to treat serious bacterial infections, and in
World War II Penicillin controlled serious bacterial infections among soldiers (Sengupta et al,
2013). However, shortly after introduction of penicillin in the market, penicillin resistance
became a huge clinical problem, and by 1950s resistance to penicillin became almost 100%
(Spellberg &Gilbert, 2014). In response, new antibiotics were discovered and developed by
pharmaceutical companies; however, the first case of resistance to the new antibiotics was
identified during that same decade, in 1962 in the United Kingdom and in 1968 in the United
States. Afterwards, resistance has been seen to nearly all antibiotics that have been designed and
developed by pharmaceutical companies (Ventola, 2015).
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Figure 2: Antibiotic discovery and resistance timeline (Bush et al, 2011).

2.3 The extent of the problem
The problem of AMR is affecting three sectors: animals, plants, and human beings (Cabello,
2006); however, the scope of this thesis is AMR in human beings in hospitals.
On the side of human being, AMR has dramatic consequences on health; however, the indirect
impact of antimicrobial resistance are beyond health risks; for example, it has a negative effect
on development; in addition, it is a drain on economy with many economic losses due to reduced
productivity caused by sickness (of both human beings and animals) and higher costs of
treatment (Regea, 2018).

2.3.1 Effect on health
Antibiotic resistance problem is rising dangerously worldwide, bacteria are acquiring new
resistance mechanisms and have the ability to transfer from one place to another and spread all
around the globe. Infections such as pneumonia, tuberculosis are becoming difficult to treat and
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sometimes impossible to treat because antibiotics become not effective. The problem grows
especially in the countries where purchasing of antibiotics is easily made over the counter and
there is over prescription by health workers and over usage by the public (WHO, 2019)
For example in the United States of America, it was estimated that around 50.9 % of bacteria
causing surgical site infections are multidrug resistant (Li & Webster, 2018).
In another example according to WHO report which gather information from 22 countries, the
proportion of patients who have blood stream infections due to resistant bacteria ranged within
countries from zero to 82% depending on application of the standards of antibiotic usage. (WHO,
2018).
2.3.2 The status of Antimicrobial resistance in Egypt
Egypt is one of the low and middle-income countries (LMIC) where data regarding endemic
antimicrobial resistance are sparse, especially because over-the-counter antibiotic use is common
(Abegunde, 2007). Data from resource rich settings and hospitals is generally better compared to
that in the community and resource limited settings (Ayukekbong, 2017). The striking findings
about AMR have been recently detected in Egypt; the prevalence of AMR is almost 90% of the
bacteria circulating hospitals.
The information in Egypt is sparse; however, the current data is alarming. According to a study
done to assess the resistant microbes in five hospitals in Egypt from 1999-2000, high rate of
microbial resistance was detected, 70% of gram positive infections were resistant. Resistance
among gram negative bacteria is higher, resistance ranges from 94% , 62% and 48% according to
the type of antibiotic which called at that time urgently for nationwide surveillance to monitor
these patterns in Egypt (El Kholy et al, 2003).
16

This was followed by another study in 2006 to assess the rate of resistance by active surveillance
in three big university hospitals ICUs in Egypt from 2006-2007. 600 isolates were detected from
which around 80% were resistant in gram negative bacteria and 60% resistance in gram positive
bacteria. Again this highlights the urgent need for actions to augment infection prevention and
control and setting the standards to be strictly followed (Saied et al, 2011).
Another study was done to study the microbiological profiles, and investigate the increasing rate
of mortality in intensive care units in three hospitals in Cairo University only. Between 2009 and
2010, the study revealed high level of antimicrobial resistance in different gram negative bacteria
ranging from 85% to 76% of resistance which differ according to the type of bacteria isolated
(El-kholy et al, 2012).
In 2013 there was a trial to develop a surveillance system in Egypt and a study was published
from a joint project between the Egyptian ministry of health and center of disease and control
(USA) stated that, from twenty eight hospitals with 91 ICUs were investigated for the prevalence
of multidrug resistant bacteria, the percent of resistance ranged from 92.8 to 54% according to
the type of bacteria. The paper also called again for urgent sustainability of the surveillance
system and enhancing infection prevention and control to contain the problem (Talaat et al,
2016).
2.3.3. Health system barriers in Egypt
Egypt has a huge issue in the fragmentation of the Egyptian healthcare system which make
setting the standards and implementation is hard. There are different providers and different
financing agents either public, private, NGOs or public private partnership (Haley & Bég, 2012).
These different agencies are managing the healthcare sector under various authorities in the
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government with different laws and levels of independence (Muleady-Mecham et al, 2009)
which make controlling people’s behavior, monitoring and evaluation extremely difficult This is
an alarming level of bacterial resistance which highlight the fact that widespread antimicrobial
resistance exists in Egypt and need immediate interventions (Gladstone, 2017).
Due to this Egypt embraces the WHO global action plan to develop the national action plan to
combat antimicrobial resistance in Egypt. This Global action plan was approved by all member
states. The WHO plan adopts the one health concept which states that people’s health is
connected to animals’ health and plants’ health, it is a collaborative approach at the regional,
national and global level for better health outcome for all (CDC, 2018).

2.3.4 Effect on development:
AMR will hamper and impede the implementation of the Sustainable Development Goals 2030
(WorldBank, 2017). In contrary to the SDG 1 ,which states that no poverty, AMR will be
driving around 24 million people into extreme poverty (Cecchini, 2015) and potentially resulting
in millions of deaths which is also against SDG 3” Good health and wellbeing” (Barredo, 2015)
Moreover, it will result in increasing inequality which is against SDG10. Sustainable
development goals are strongly interconnected with the containment of AMR; thus, failure or
loose actions towards AMR would definitely make these SDGs less likely to be achieved (World
bank, 2017).
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2.3.5 A Threat to the Global Economy
The worldBank has made a simulation to the spread of AMR from now to 2050 to quantify the
global losses, and attract the policy makers and draw their attention towards the problem
(Shrestha et al, 2018). Two scenarios were set; one scenario with low AMR burden, and another
scenario with high AMR impact. The models and scenarios were based on the economic effect
on the labor supply and livestock productivity (O’Neill, 2015)
In the scenario of low AMR impacts, the simulations found that, by 2050, there will be a decline
in the annual global gross domestic product GDP by 1.1 percent, relative to a base-case with no
AMR effects; the decline would exceed one trillion dollars annually after 2030. In the other
scenario with high AMR-impact, the loss worldwide will be 3.8 percent of its annual GDP by
2050, with an annual loss of $3.4 trillion by 2030 (World bank, 2017).
By comparing the losses due to AMR in the period through 2050 and the losses due to global
financial crises, we found that the reduction in global GDP caused by AMR will be equal to the
losses provoked by the financial crisis, at their most severe (Van Boeckel et al, 2015). However,
the impact of AMR is worse because the repercussion would be felt during the entire period until
2050, not just for a couple of years, as was the case in the acute phase of the financial crises
which has occurred recently (Michael, 2014- Friedman, 2016). The economic inequality between
countries would increase (Levy, 2001), and this would happen because low and middle- income
countries (LMIC) would experience larger drops in economic growth than wealthy countries.
Low and middle income countries will have higher prevalence of AMR and greater dependence
on labor incomes (Singer, 2016), and most of the burden would occurs in low-income countries.
With increasing the disease burden by 2050 and rising the AMR, the healthcare expenditure,
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both public and private, will exceed 25% in low income countries, where the prevalence of AMR
is highest, and 15% in middle and 6% in high income countries (Economou, 2015).

2.4 Protecting a Global Public Good
Containment of AMR is considered to be protecting a global public good. This is because all
countries can enjoy the benefits of successful AMR containment; on the other hand, all countries
will be harmed if AMR is remained without being curbed and controlled (Saleh et al, 2015).
This responsibility is held on public authorities, especially national governments, in protecting
this good and prevent spread of pathogens, including drug-resistant strains (IDSA, 2011).
The loss of efficacy of antibiotics and other antimicrobials worldwide can be understood as a
common goods curse (Holmes et al, 2016). The problem of commons occurs when people in a
community waste a limited, shared resource, as each one pursues own self-interest by exploiting
the resource for private benefit. No one wants the common resource to be exhausted. However,
the group’s behavior leads to precisely this result. This was the same case as in the collapse of
fisheries due to overfishing, for example. The overuse and misuse of antimicrobial drugs
worldwide show a similar pattern (World Bank, 2017).
2.5 The role of stakeholders in the control of antimicrobial resistance
There is no sole institution responsible for controlling antimicrobial resistance. The
responsibility is shared between healthcare providers and others (Silbergeld, 2008) However,
continuous education is mandatory for physicians and scientists to be aware and learn the
importance of evidence based and good prescription practices. Other stake holders who include
general population and government also play a fundamental role. Governments ought to put this
issue as a priority and a public concern. Polices and regulation should be set and enforced in their
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implementation; in addition, monitoring and evaluation of these implementations should be done
to ensure that policies are applied effectively (Blakely et al, 2006).
The population on the other hand was perceived by researchers as a vital sector who needs to be
educated on the threat of Antimicrobial resistance. The role of Media professionals appeared to
be the link to convey this message to the population and consequently they require adequate
training on conveying scientific and medical information in simple language (Eysenbach, 2008).
Other researchers stated the importance of using multiple channels to learn population about the
consequences and unsafe practices that increase the emergence of multidrug resistant bugs and
recommended this as another important approach. This approach had shown success when used
with journalisms to fight HIV/AIDS in developing countries, and many policy makers are
expecting that it will be effective also in Antimicrobial resistance. There are a number of
initiatives have been done to fight AMR by the governments in developed countries but these
initiative are still limited in developing countries due to financial stress and limitation of the
resources (Ayukekbong et al, 2017).
Currently, the international health care bodies acknowledged the importance of the critical
situation of antimicrobial resistance crises and its effect on the human nature (Kuehn, 2013).
These bodies are concerned with solving the problem and managing the crises. They
provided a number of regulations and recommendations which could lead to actions taken by
governments to address this serious issue. Indeed, these recommendations lead to programs
and chain of actions in a trial to contain the problem; the actions fall in two categories: either
prevention or control (Hidron, et al, 2008). The idea is that with prevention, the need for
antimicrobials will be limited because the problem will be prevented from the start. With
control they aim to provide new antibiotics which are more effective than the currently used
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antimicrobials. In conclusion the measures that were taken aimed to prevention through
controlling the bugs, vaccination, and educating public and clinicians about the standards of
antimicrobial usage (Laxminarayan et al, 2013). Governmental legislations are mandatory to
emphasize the implementation of policies (Harmsen et al, 2013). All the initiatives which
were taken by the international bodies had proved success; however in this problem, the
frequency by which the infectious bugs are evolved and propagated in the communities gives
an alarm that these actions need to be expanded and more actions are needed to be added to
contain the problem. (World Health Organization, 2012).
2.6 The gap in the research that the thesis will fulfill
The causes which lead to prevalence of antimicrobial resistance differ from one country to
another. In developing countries, root causes are more complex from developed ones. Most of
the current research about antimicrobial resistance is targeting the resource limitedness and lack
of infrastructure in the developing countries (Aslam et al, 2018). Other researches are looking for
new antibiotics to kill the microbes and urge the pharmaceutical companies to design new
antibiotics in the pipeline (Li& Webster, 2018). The current Research lack the behavioral aspect
of healthcare practitioners and patients’ in using antimicrobials. These factors include inadequate
prescription of antibiotics, inadequate patient and clinician’s education, and lack of experienced
personnel and presence of antibiotics on the counter to be sold without prescription. Thus, the
intervention efforts should be home-planned and based on the factors prevalent in the developing
countries to meet the needs of this part of the world. These root causes if managed could be and
its importance as it could be an easy and effective solution in controlling the risk of antimicrobial
resistance and this will be assessed by this thesis. Taking the interventions in the developed
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countries as a guide will be beneficial; however, we cannot depend on them blindly and must
take the situation of developing countries into consideration (Podolsky et al, 2015).
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Chapter Three: Research Methodology
3.1 Design
The research question is to detect the extent of implementation of WHO international policies
for antimicrobial resistance in the Egyptian hospitals, and to reach our target we used
qualitative research methodologies. The qualitative method aims to gather in-depth
understanding of social behavior and the reasons that govern such behavior (Yilmaz, 2013). As
this problem is considered to be a collective social behavior, data gathering will depend mainly
on qualitative research methods. The methods will focus on meanings, views, and perceptions,
where participants’ description of the situation will be highly valued. Multiple methods of
qualitative research will be used including in-depth interviews and participant observation. This
variation is valuable as it will allow triangulation and ensure validity and reliability of data.

3.2 Methodology
The interviews were designed to be semi-structured based on flexible structure with many
open ended questions to explore the issue broadly. This was followed by in depth questions to
study certain issues in details, such as the training and policies physicians use to contain the
problem of antimicrobial resistance. In addition, further questions were designed based on
what the interviewee have said to obtain more clarification and details (Britten,1995).
The following table gives a descriptive data about the interviewees, their positions, years of
experience, the educational background and the working sector. Interviewing physicians from
different backgrounds, working sectors and positions was mandatory to collect a clear view
about the situation.
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Table 1: Data about the participants to the interviews.
Code

01

Status

Representative from the

Years of

Educational

Working

experience

background

sector

>20

hospital administrative council

02

Department head in

>20

international health

Laboratory

Public

consultant

hospital

Laboratory

International

consultant

organization

Specialist

Public

physician

hospital

Consultant

Public

Physician

hospital

Resident

Public

Physician

Hospital

Nurse

Public

organization

03

04

05

06

Chest physician

ICU physician

Internal medicine

Surgical nurse

7

15

5

6

hospital

25

07

08

09

Lab consultant

Lab specialist

Infection control practitioner

10

8

3

Clinical

Public

microbiology lab

hospital

Clinical

Public

microbiology lab

hospital

Infection control Public
doctor

10

11

Infection control practitioner

Pharmacist

4

8

hospital

Infection control Public
doctor

hospital

Pharmacist

Public
hospital

Moreover, Observational method was used to systematically observe and watches people in
their normal settings and working environment thus it was an effective way to find out
people’s behaviors and actions in their working places (Pope et al, 2000). This way was
important because it required going to the field and studying the whole situation followed by
describing and analyzing the field. In health care settings this method has been proved to be
profound and descriptive (Mays & Pope, 1995).
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Table 2. Schedule of observational study
Day/ February

Observational site

Saturday / 2nd

The infection control

Sunday/ 3rd

The microbiology lab

Monday/ 4th

The inpatient pharmacy

Tuesday/ 5th

The ICU

Wednesday/ 6th

The surgical department.

Thursday/ 7th

The chest department, The internal medicine
department

Friday/ 8th

The obstetrics and gynecological department

SWOT analysis was added as a tool to identify core strengths, weaknesses, opportunities, and
threats lead to evaluate recommendations and new ideas to solve the problem (Van
Wijngaarden, et al, 2012).

3.3 Sampling
Purposive sampling strategy will be pursued in choosing the participants; preliminary criteria
relevant to the research objectives will be predetermined to guide the selection process
(Guetterman, 2015). The selection criteria are as following: all participants who are working in
the medical field and have direct or indirect effect on the rate of AMR in the hospital; in
addition, all stakeholder which includes representatives from the WHO will be interviewed.
Interviews are an effective qualitative method for getting participants to discuss their personal
encounters, opinions, and experiences (Alshenqeeti, 2014). In turn, eleven interviews will be
27

conducted and intended to include participants from different medicinal fields.
Interviews questions are designed to elicit a vivid picture of the participant’s perspective on
the problem and the current status of AMR. The questions are prospectively semi structured to
let interviewees talk freely, and probing questions will be asked if the discussion skewed to
unneeded direction.
All interviews are conducted in Arabic, then translated and transcribed in English by the
researcher. Before conducting the interviews, all participants will be informed about the
nature, purpose and possible outcomes of the research through the written informed consent.
The interviews handouts will be kept confidential and the data will be analyzed and interpreted
by the researcher.

3.4 Limitations
Limitations in the interviews: The size of the sample is limited to the number of the interviewees,
and also limited to the area in which the interviews are expert in. The quality of the interview
depends mainly on the respondents; in addition, the response may be subjective. We will not be
able to meet and interview patients to assess the situation from their view.
Limitations of observational study: Many behaviors are not open for observation and also cannot
be quantified by observational techniques. Moreover, observational study is subjective and needs
experience from the observer to avoid personal bias or pre-conceptions which could kill the
objectivity in research.
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3.5Ethical considerations
All interviews and observational study were held in the period between January and
February 2019, after the IRB approval (Annex 12). The interviews were done in Arabic
language then translated by myself. Before the interview, all interviewees were informed
about the research and outcome and signed the informed consent (Annex 13). All
handouts were kept confidential, and the data was interpreted and analyzed by myself.
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Chapter Four: Findings and Discussion
Interviews are effective qualitative methods for allowing participants to discuss their
opinions, and experiences (Mack et al, 2005). In turn, eleven in-depth interviews were conducted
with personnel who are involved in dealing with patients and prescribing antibiotics. The
interviewed participants were of different specialties and ages; they were physicians from chest,
ICU and internal medicine department, deputy dean for environmental issues, infection prevention
practitioners, Lab specialists, pharmacists and nurses and the head of communicable diseases in
WHO Regional Office for the Eastern Mediterranean EMRO. Most of interviewees aged from 25
to 35, and some of them aged 45 to 60 (table 1). Moreover, observational study was done during
the regular working days with nurses and physicians, Lab specialists and the pharmacy. This
variation was extremely important because it helped triangulation and ensured validity and
reliability of data.

4.1 Interviews themes and discussion
The first interview was conducted with the vice dean of the hospital for environment issues,
she joined the organization since she was resident; this was 23 years ago and she was promoted
during her career until she reached this position. She knows every aspect in the hospital and what
was surprising that she knows most of the problems facing the institute from the infection
prevention and control issues and she knows the ideal solutions, but the solutions are difficult to
be implemented on the ground due to many reasons; one of them is financial issues. The interview
was in her office. It seems that the decision is centralized and she had to look into every matter in
details by herself and give a decision in every single aspect. There is no delegation or
decentralization of tasks (Annex 1).
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The second interview was with a department head in international health organization
concerned by the problem of MDR in Egypt. She was pessimistic about the situation in Egypt. She
praised infection control department in Alexandria University. However, she mentioned that jobs,
such as infection control, stewardship of antibiotics in most places in Egypt are part time jobs but
these jobs require full-time. In addition, people are not compliant and there are no strict rules to
follow. She stated that the national action plan had been released to fight multidrug resistant
bacteria, but it is not for public yet and will not be found on the Internet. She stated that the
International organizations, such as Center of Disease and Control (CDC) and World Health
Organization (WHO) are not funding agencies, and they are only agencies for consultation and
gives advice to nations. The government in Egypt has to set its own policies and the way they are
going to implement, monitor and evaluate and in her opinion, we are still there and away from
stated goals.
Another interview was with an assistant lecturer (a position after completing residency
and had master’s degree in the specialty) and the one responsible in the chest department. Residents
and assistant lectures are the ones who are doing almost all the work in the wards, they are making
rounds to assess the cases of patients, prescribe antibiotics and following up the patients. The
interview took place in the ward with a lot of noise and interruption either by the patients or the
nurses. The physician looked very busy and exhausted; in addition, he knew nothing about the
antibiotic policy, he was only exposed to some concepts of the infection prevention and control
during his residency. The physician knows that the problem is huge and there are many MDR in
the hospital, but do not know how to improve and they are dealing with the situation to isolate
patients if they have a space for isolation. He do not know anything about the global action plan
of the WHO (Annex 3).
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The fourth interview was with Lecturer in the intensive care unit (ICU); this was a midsenior staff dealing patients, most of them harbor multidrug resistance bacteria. The physician
know that the problem is big and around 70% of patients capture these kinds of bacteria die not
from the original disease but from the bacterial infection which is not responding to antibiotics.
The interview was in the office, and there were many interruptions from nurses and junior doctors
who were asking for consultations. Junior doctors were always asking about prescribing antibiotics
and the doses required. Nurses were asking for supplies which are not sufficient and want to
purchase more supplies from donation money. The physician do not have antibiotic policy but he
tried to teach himself about antibiotics. He had never received training about infection control, yet
he finds it important and crucial for safe environment. He is looking forward to have a program to
train junior physicians, but he do not know anything about the initiative of WHO (Annex 4).
The fifth interview was with a resident in internal medicine department. The office of the
residents was very missy and crowded with around five residents in a same small room. The
resident had a night shift the day before and he supposed to work for the next 24 hours also. He
was very tired and was giving short answers and seemed not to be interested. The resident knows
the problem is increasing and getting difficult to have quick fixes. The department develop its own
internal antibiotic policy and they are following. They do not receive any general antibiotic policies
from the hospital and he did not receive any training. In addition, he does not know about the
WHO initiative and global action plan. The decision to isolate the patient or not is very subjective
i.e some physicians isolate if the patient has MDR infections, others not (Annex 5).
There were two interviews with infection control practitioners, one responsible for the
orthopedic department and the other is responsible for the intensive care units in the hospital. The
meeting was in their offices where the interview was very friendly. The place was quite with little
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interruption. One of them was more knowledgeable than the other, both were the same age mid
seniors, just completed their doctorate degree, they were active and responsible and want to
improve the infection control situation in the hospital. They both declare that MDR is a huge
problem in the hospital and everywhere in Egypt. The infection control guidelines are written and
updated by Ministry of health every 4 years, which is not enough to cope with the rapid change in
the epidemiology of bugs. They stated that implementing and monitoring the policies is a very
difficult part. The policies are not distributed to all physicians and nurses, they are only with
infection control committee. Implementing policies needs training first followed by continuous
monitoring and evaluation by monitoring tools such as infection rate and surveillance. There are
different ways to ensure compliance of people either praise or punish but most of the time punish
works better and this is sad. We try to monitor the infection rate by the surveillance but I find the
infection is rising. Infection control is a part time job and without resources it means that no
infection control policies could be applied effectively on ground. They stated that the main factors
increasing the infection rate and level of MDR resistance is the misuse of antibiotics by physicians.
The infection control practitioners are working hard with the limited resources they have, they do
not know about the initiative of WHO global action plan; however, they are applying their own
objectives which by the way the same as of the WHO objectives (Annex 6, Annex 7).
Two interviews were conducted with Laboratory consultant and laboratory specialist in
the lab. The lab was busy with many technicians and physicians, many times patients or nurses
come into the laboratory to ask about the results and interpretation or availability of clinical tests.
There was high interruption but the lab doctors were very cooperative. They stated that MDR is a
huge problem affecting the whole world, they do not know the GAP initiative but they know that
there should be a national plan to contain the problem of antimicrobial resistance otherwise the
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situation will be critical. They are doing the antibiogram to trace the change in the behavior of the
bacteria every 6 months but they are doing this on demand i.e if any ward want to know its
antibiogram they make it otherwise it is not part of their routine work. There is no connection
between the Lab and the pharmacy which means that the lab may be testing for the sensitivity of
certain antibiotics and these antibiotics are not available for dispensing in the pharmacy and vice
versa may be the pharmacy has different types of antibiotics but the lab is not testing them in the
sensitivity thus they are not reported in the sensitivity report and the physician won’t know about
these antibiotics to dispense them for the patients. In addition, there is no communication between
the lab personnel and the physicians to consult about cases and their management. Physicians are
so busy and Laboratory doctors as well; moreover, there is no intranet or working internal phones
in the wards for communication. The lab request missed many important data about the patient’s
case and diagnosis which make the interpretation of data from the lab defective and call for urgent
communication with physicians. From the lab opinion, surgical wards and operating rooms are the
highest wards with infections and managing these wards means that we managed almost 60% of
the problem. The major cause of the problem is the misuse of antibiotics either it is empirical
antibiotics or wrong dosage or wrong duration because most of physicians do not know anything
about antibiotics and its right usage (Annex 8, Annex9).
The tenth interview was with a nurse from the surgical department. This is a senior nurse
who is working for 24 years in the surgical department. The interview was on the counter of nurses
in the ward were the files of patients and medications to be administered. This was the night shift
from 8 pm to 8 am, it was somehow quite comparative to the morning shift. The nurse was cautious
at the beginning because she did not understand the meaning of the interview, but after a while she
became at ease and friendly and started to say all the negatives in the ward because she wanted to
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improve and asked me to try to send her suggestions to the dean. She stated that the problem of
MDR is a huge problem and it was taken lightly in the beginning until one of her friends caught
chest infection with MDR bacteria and she was treated for almost 6 months until she recovered
with remaining complications. She found the infection control policies important. But cannot be
implemented in these crowded and busy hospitals where the infrastructure is not compatible with
infection control policies. The patients are sitting side by side and the number of nurses is very
defective. They do not have the infection control policies in hand it is only with infection control
nurses, and they are receiving infection control training may be once a year. The measures they
usually take to prevent transmission of MDR is isolation but this is not available all the time
because of the limited places and the decision depends on the physician, thus it is subjective
decisions. She did not hear about the initiative of the GAP WHO before but she found the
objectives of the global action plan important and feasible for application (Annex 10).
The last interview was with a pharmacist in the main pharmacy of the hospital. There are
many branches for this pharmacy, two internal pharmacies in each hospital for the inpatients and
one in each hospital for the outpatients. The concept of clinical pharmacy is still new in this
hospital and there is huge resistance form the physicians to allow the pharmacist to prescribe the
antibiotics, adjust doses and decide the frequency of therapy. The pharmacist is in mid-senior age
and she confirms that the problem of MDR is serious problem. She states that there are no general
antibiotic guidelines for the hospital, it depends on every department or it is culture based which
leads to misuse of the antibiotics. The decisive and final decision in antibiotic prescription is for
the physician and the role of the pharmacist is only as a consultant if the physicians ask for his/her
consultancy. She stated that there are initiatives to start a committee to control the antibiotic usage
which is the stewardship committee but it is still an idea. She do not know what is the GAP
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initiative; however, she is convinced by the objectives and wants to apply to find a way to control
this huge problem (Annex 11).

4.2 Observational study
The observation was for one week and was divided based on a preplanned schedule (Table 2).
One day spent in the infection control department, one day in the microbiology laboratory, one
day in the inpatient pharmacy, 4 days in the wards of different departments to see the
environment of the nurses and physicians and how they are dealing with the patients.
The observational study was very useful to study the actual and true environment and analyze
how people are interacting and dealing with each other. On the first day, there was a visit to
infection control units at 9 a.m; however, the nurses did not show up except at around 10
o’clock. The high nurse went for audit on the surgical ward, and what was very distinguishable
that the audit was for nurses only, not for physicians, there was a physician who was not wearing
gloves from patient to patient and the infection control nurse only gave a comment to the
physician very nicely and he did not respond to her. The nurses of the ward were compliant to
the infection control policies; however, the wards were extremely crowded, there were no spaces
between beds. The nurses complained that there was no alcohol or gloves and they were
purchasing gloves out of their pockets, and the infection control nurse responded that the hospital
has no resources now try to adapt yourself. One of the patients complained that the nurse did not
change the dressing for 3 days however it was soaked with blood, the infection control nurse
wrote this to be reported and asked the nurse to change the dressing, but the nurse complained
that their number is too low to the number of beds in the ward and they need more nurses.
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On the second day in the microbiology laboratory, the working day which started at 9a.m and
ended at 1 pm. There were eight technicians and three doctors per day, one of these three doctors
is a supervisor; thus the working hands are only two physicians responsible for the routine work
which is around 100 samples each day. During the four working hours, all people were very busy
working, and responding to the queries of the patients and nurses, which gives a high prediction
for human error. There were no gloves and the sterilium bottle was empty. They were working
with their bare hands without gloves. People were touching all surfaces with their hands which
means they are transmitting infections everywhere. Officially patients are not allowed to enter
the laboratory; however, they were getting in the lab asking for test results. The workload was
extremely high for four working hours; moreover, some doctors were required to finish their
work and then go as a part timer in the infection control department. There was no time to
communicate with physicians or pharmacists, or to give training for nurses about sampling.
The pharmacy on the third day was very crowded with pharmacists and nurses. The pharmacy
opened at 9 a.m, nurses bring the patients’ files with the requests for the antibiotics. Dispensing
of antibiotics, doses and frequency based on the physician’s request not based on isolation of the
organism and detecting the true antibiotic sensitivity specific for this organism. The policy is that
dispensing of antibiotics based on isolation of the causative organism and doing antibiotic
sensitivity; however, no pharmacist was asking for the culture results and when by asking them
why the policy is not followed, the response was that they will not postpone the antibiotics for
patients based on culture and the physicians will never send it; thus the treatment for patients will
be delayed of no use. Many times, the nurses came asking for antibiotics and were not available,
again because of the resources are weak or because there is delay from the companies’ supplies.

37

No physicians came to communicate with the pharmacists, only nurses and companies’
representatives who came for pharmaceutical marketing.
The fourth day in the intensive care unit (ICU), the unit had its own policy of antibiotics. Nurses
and physicians are trained to follow this policy. The head of the ICU is very strict in infection
control policies and antibiotics policies, he set rules and no one is allowed to break these rules.
They have plenty of resources which come from donations. The spaces between beds are
preserved and the nurse bed ratio is maintained. The work for nurses is divided to three shifts
each is eight hours; however, for physicians there is shortage in number and the shifts are for 36
hours. The physicians were extremely exhausted and stressed. There are strict regulations of no
entry except for people working in the ICU; thus, only few hours were allowed to stay there.
Each nurse is responsible for two patients and taking care of every single item. The infection rate
in ICU is still high because there are many devices piercing the skin barrier, such as cannulas,
ventilators, central venous lines etc, and because they are receiving terminal cases from the
regular wards.
The fifth day was in the surgical ward, surgeons from observations are different from all other
physicians. They are not believing in bacterial infections and the presence of MDR infections,
and not following the policies of infection control, and they are very resistant to any change.
They believe that once the surgical operation is successful then their role is done. They do not
care about infection or bugs that patient can capture before, during or after the surgical operation.
They are very hard minded and very difficult to be convinced. They need long times of
negotiations and leadership commitment to be convinced about the presence of microorganisms
and bacteria. Nurses are more committed than physicians because the infection control audit is
for nurses and the nurse who is not following polices will receive a punishment. Number of
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nurses is lower than the normal nurse: patient ratio which is between 1:4 or 1:6, the ratio in the
surgical ward was around 1:15. There was lack of resources as well. I stayed until 8 p.m;
however, no one of the surgeons showed up in the ward, it seems that they were spending all the
day in the operating rooms for surgical operations. There were interns in the ward and they were
taking care of the patients and can call the resident in any serious situation. The ward was
crowded and the number of patients was exceeding the capacity of the ward. During 2018, the
percentage of surgical site infections in the ward was around 5% on average; however, in
October there was an outbreak in surgical site infections i.e patients with surgical sites after the
operation were capturing infections in their wounds which lead to failure of the surgery or septic
infections. The outbreak, which means that many cases were infected by the same MDR
organism, was discovered by the infection control team in late October, the infection control
team applied a bundle of actions to control the infection and disinfect the ward. By tracing the
outbreak back, they discovered that the primary case was a patient admitted from the emergency
department with stabbed wound in the abdomen. The patient had MDR bacteria and transmitted
it to patients in the ward either from the patient by contact, or from the physicians who do not
wear gloves. The outbreak was controlled, and the infection control head notified the head of the
surgical department officially by the incident, and since then there is some sort of commitment in
the surgical wards which confirms the same concept that managerial commitment is required to
change people’s behavior.
The sixth and seventh days were in the chest, internal medicine and obstetrics and gynecology
departments. They were very similar to each other; wards were crowded with patients and their
relatives. There was no restrictions for visits of relatives. Nurses were trying to implement the
rules of visiting of relatives but relatives were waiting everywhere. Beds are beside each other
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with no enough space to prevent transmission of infection from one patient to another. Patients
were bringing food and drinks from outside the hospital and hiding them in pillows or blankets,
so not to be discovered by the nurse. The number of nurses compared to patients is very
defective which indicated less care for patients. Nurses did not wear gloves because everyone
should purchase gloves out of their pocket and gloves are expensive. Patients were complaining
from lack of care and that they may stay for days without antibiotics or routine care from nurses.
The bed sheets have some old stains on it and look pretty old. There were only four nurses for
the whole ward with 60 patients. No physicians were seen and when asked about them nurses
responded that they were in the operating rooms or in the outpatient clinics and will come at
7pm. They were three residents in the ward. It seems that they were overwhelmed by many tasks
and duties and this explains why there is no time to communicate with other departments such as
the Laboratory or to receive trainings for antibiotics or infection control or knowing about WHO
global plan. At around 6 pm residents started to come to the wards looking exhausted they sat in
their room looking into the patients’ files. Patients started to leave their beds and come to ask
them about their queries. They look nervous and told patients in a high-pitched voice to return
back to their beds and that they will coming to them in the ward. They started their rounds from
patient to another. They were examining patients without washing their hands or wearing gloves
due to lack of resources or because they were overwhelmed by tasks. They then finished their
rounds, returned back to their room, and wrote their observations in patients’ files.

4.3 Research findings
It is extremely important to assess whether healthcare personnel are aware of the situation or not
; thus, a question was introduced at the beginning of the interview to know the percent of their
awareness about the problem. It returned back that all sectors of healthcare personnel know the
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problem and aware of its consequences and this was obvious in their responses “Yes, I know
there is MDR problem and I am convinced that this is a big problem, gram negative organisms
are the most common”. This quote was received by all the interviewees which gives a clear
vision that the issue became clear and well known to all.
However, by probing the question, another finding was detected about the limitedness of
facilities they have. This was reflected by their response “There is no space for isolation of
patients” (chest and ICU physicians). Absence of resources or its limitedness was the first
finding detected and the clearest one; moreover, this finding was expected in all public hospitals
that depend on governmental funding.
Digging deep in the interviews to elucidate the behavioral factors, communication factors that
represent a huge part of the problem. The research discovered that absence of standards and
guidelines lead to individual decisions based on one’s experience. ”The physician knows that this
patient is MDR and we isolate the patient” (surgical nurse). “We give him the sensitive antibiotic
and isolate” (ICU physician). The opposite response that received from two different physicians
about the way they are dealing with a case of MDR bacteria illustrate that there are different
directions in ways of treatment not on definite policies or regulations to face the problem but on
personal concepts.
Deeper in the interviews another concepts were discovered, in the core elements that should
control and prevent resistant bacteria for example, there are no written distributed policies about
infection control or antibiotic policies; thus, healthcare personnel including physicians lack the
essential knowledge for proper usage. The response received from physicians was shocking “I
don’t have a copy of the infection control policies and no one told us about it except few
times”(chest physician) another physician replied the same “I do not have antibiotic
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policies”(internal medicine physician). These results give an overview about the huge problem of
education and training that healthcare workers suffer from and shed light on the importance of
studying these root cause taking into consideration the huge effect of these cause on the
consequences of the problem. By probing the question, another fact was realized that with lack
of standards, everyone will set his/her own policy which will lead to huge corruption in
management of the problem. When some physicians were asked about how they treat their
patients, they responded that “we have an internal policy for antibiotic use (ICU physician).
Definitely this creates a gap in application of a generalized plan and unified steps to reduce the
burden of AMR in the hospital settings.
In testing the response of healthcare workers on importance of guidelines and standards, the
response was surprisingly positive and they know that these policies are extremely important to
prevent the problem. “However, I find infection control is important”(chest physician). These
findings illustrate the need to have a systematic training, education and standards to facilitate
medical interaction in the right way and thus decrease the behavioral part of the problem.
Absence of leadership commitment is another factor that leads to failure of good initiatives. On a
trial by infection control practitioners to set a surveillances system to monitor the MDR in the
hospitals; the problem was in the application of the system and this was because of lack of
support to workers in the system financially and by time and the initiative ended up by being
inefficient as stated by one of the infection control practioners. “If the surveillance is well
planned and implemented in the right way with regular follow up it will reduce the rate of
infection because this is a way of tracing infection. But this is not happening in the right way and
also it depends on the leadership and commitment” (infection control practitioner). Commenting
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on this finding, lacking of leadership commitment is another issue which affects the problem in a
negative way.
To understand whether the different departments have communication with each other or not,
questions were introduced in each department to physicians and nurses to understand how
different departments are communicating to finally reach a decision for the patient. The most
striking finding was that each unit in the hospital is acting as a separate entity and there is no
communication between the departments, the lab has no connection with the pharmacy as stated
by a pharmacist “No we do not have any connections with the Lab” (pharmacist), and physicians
have no connection with the lab; as stated by a lab physician “We are not consulting the
physicians” (Lab consultant) and another one “We do not have time and it is difficult to reach
them”(Lab specialist). In conclusion, they are not notified about the presence of MDR bacteria
infecting their patients except after days; consequently, treatment of patients will be delayed or
mistreated and the problem aggravates. . Another finding discovered from the interviews with
the Lab specialists that diagnosis of MDR bacteria in the Lab is not considered critical to be
notified to the physicians immediately and that most of cultures revealed MDR bacteria which
indicates that it became like an endemic pathogen. The problem of AMR in hospitals and its
prevalence is mainly seen as a problem of behavior and resources; however, behavior comes first
and contribute to more than 70% of the problem, such as the misuse of antibiotics, lack of
communication between the lab and physicians and lack of managerial commitment”.
Consequently, if we look into the objectives of GAP to estimate to what extent the WHO plan is
implemented, we will find that the plan and its objectives are met by about 40% if we considered
that objective 2 and objective 3 are met; however, objective 1,4,5 are not met.
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Figure 4: Objectives of GAP of WHO (Bhatia, 2018).

4.4 Themes for answering the sub research questions:


All sectors of healthcare personnel know the magnitude of the problem and aware of its
consequences and are afraid from spreading of the risk in the community. This was clear
in their quotes “Yes, I know there is MDR problem and I am convinced that this is a big
problem. Ecoli and Klebsiella are the most common”(All physicians). These quotes were
common among all the interviewees who stated that the risk is very high and the
causative agents are very aggressive as well. However, due to absence of unified set of
policies, each sector is trying to contain the problem from its own perspective and
depending on the resources they have, but they do not have the facilities to deal
efficiently with the problem, and this is clear in the quotes” I manage according to the
patient clinical situation. If the clinical situation of the patient is ok, the patient stays in
his place and continue treatment without isolation because we do not have enough
isolation rooms” (03), this is different from the other physician who stated that “Sure I
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isolate the MDR patient “(04). These different decisions indicate that lack of standardized
policies make the decisions subjective.


The global action plan of the WHO is not known to anyone, the vice dean for
environmental and infection control among the healthcare workers was the only one who
knows about it. There was no announcement about this action plan or the objectives of
the WHO. This means that the WHO needs to expand and reach all healthcare sectors to
convey their messages because their messages only reach to certain categories of people
who are the managers or deputy managers but not go deep to other sectors. The same
response was received from all healthcare workers when asked about the initiative “I do
not know about this”(all physicians). Lack of publicity is another major factor in
spreading the risk because people do not know about the causes of the risk or the actions
they should take to manage the problem.



Healthcare personnel are taking steps to detect and combat the risk. Infection control
practitioners are making the surveillance to capture the whole picture of MDR and
monitoring the change in infection rate rapidly “We have the surveillance program
collected by nurses to enter data of patients in daily audit and monitored daily then
notify to the infection control doctor. These data is entered by infection control nurses.
This is a program affiliated to ministry of health and ministry of higher education in
joint with the Center of Disease and Control (CDC)”. But the final report usually
missing important data because they are not well trained on the system “if the doctor or
nurse who is writing the report is knowledgeable, he/she will write important details but
this is not always happens.” (09, 10) Nurses are following the policies because there is
continuous audit and monitoring, punishment and praise; but their number is lower than
45

the required nurse to patient ratio; thus, nurses are always drained and exhausted; In
addition, lack of resources is another burden as seen in the surgical nurse quote “The
place is very crowded and busy and every patient is sitting in close contact to the other
patient. There are no isolation rooms only one room in the department” (06). Physicians
are dealing with patients depending on the situation, and all actions are subjective
depending of the present physician. They know the problem but lacking standardized
polices and rules to follow. Their quotes represents their situation “there are many
problems I cannot do anything with it, such as absence of isolation rooms, the
crowdedness of patients and the disease can be easily transmitted from one patient to
another”(05); however, they are doing their maximum effort to contain the risk.
•

There are many impeding factors which act as obstacles in the implementation of
antimicrobial resistance plan. These includes, the inadequate infrastructure represented
in the small space, crowdedness of the hospital and absence of isolation rooms.
Inadequate resources and dependence on donations is another major factor. Insufficient
number of healthcare workers to number of patients, and the huge workload are
additional factors which forced people not to follow the standards.

Table3. SWOT analysis

STRENGHTS

•

Support from management

•

Experienced personnel

WEAKNESS

•
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•

Awareness of importance of the

•

problem
•

Good understanding of actions

No one knows about the initiative of
WHO

•

required

Small group of people driving the
issue

•

Reliance on individuals rather than
institutions

•

IC and stewardship are add-ons to
already high workload

•

Implementation and monitoring

•

Weak communication with physicians
(esp. in surgical dept.)

•

Training of physicians on IC and
Stewardship policies.

•

Neglect of workers (cleaners) and
patients training

•

The role of clinical pharmacists is
minimized

OPPORTUNITIES

THREATS

•
•

Increase in the number of patients

Established infection control

dying from infections rather than

structures

cancer.
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•

Growing nat. and intl. attention to
AMR

•

Competitive public and private
hospitals

- Exchange
- Funding
•

Strong reputation of the hospital.
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Chapter Five: Conclusions and Recommendations
5.1Conclusion:
What concluded from the study that barriers against implementation of AMR plan differ in
developing countries from developed ones, the causes in developing countries are much complex
because it depends on behavioral factors in addition to financial and resource limited factors.
However, the behavioral factor is playing a major role in these countries and can be fixed by
setting the rules and have a strong leadership.
Absence of strong leadership commitment which is required to set and maintain the rules leads to
loose or absent application of initiatives such as the surveillance which was not implemented
efficiently as it was supposed to be effective in containing the problem of AMR.
Lack of standardized policies and regulations for the usage of antibiotics in treatment and
policies of infection control and absence of programmed training for residents and nurses about
infection control opens the door for subjective decisions for using certain types of antibiotics, or
applying different standards.
Lastly, lack of communication between different departments is another major challenge because
each department acts autonomously and is seeing the problem from its own side. People are
aware of the magnitude of the problem; however, do not know how to manage it with the current
and available resources. There is low publicity about the WHO GAP; however, healthcare
workers are aware by the objectives. People are welcoming any initiative from international
organizations as long as these organizations are trusted, such as Center of Disease and Control
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CDC and World Health Organization WHO, but the major concern is about sustainability which
needs a lot of money and leadership commitment and these are lacking currently.
5.2 Recommendations:
After analysis of the study a set of recommendations is developed which could help to contain
the problem;
The better use of human resources, it is important to use these human resources in a right way.
Part time jobs and multitasking are not good options. Jobs should be full-time which enables
personnel to work efficiently. Setting adequate ratio between nurses and patients, physicians and
patients and not overloading the staff is another important factor.
Authority should be given for pharmacists who are more knowledgeable than physicians in
antibiotics, their interactions and their side-effects. This should be a decision of the upper
management, implemented and followed by pharmacists. Clinical pharmacy is a well-established
branch in USA and Europe countries; however, countries like Egypt still there is strong
domination for physicians which will has bad consequences on antimicrobial resistance.
Communication with different healthcare personnel is mandatory. Physicians should be
communicating with pharmacists and laboratory physicians for better interpretation of results.
Communication will also lead to rapid detection of multidrug resistant cases, rapid management
and isolation to prevent transfer to others. Communication system is present in hospitals of USA
and Europe; however, in Egypt it is not settled yet except in some private hospitals.
Hospitals should hire full-time consultants for infection prevention and control and stewardship.
These specialties should not be add-ons to already high workload. There should be time to set
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plans, implement and monitor, then receiving the feedback to improve again. Part-time jobs with
high workload is a mess and people wont be focused on their targets.
Systematic training on infection control policies and stewardship should be given to physicians
at the beginning of their residency in the orientation program; thus, they will be exposed to these
concepts before touching patients. These programs need the commitment and support of the
higher management. Moreover, intensive training and follow up should be given to cleaning
workers who are dangerous source of transmitting infections through mops, door knobs and light
switches.
Big public hospitals should use their strong reputation and great history to make collaboration
with international organizations for capacity building and funding opportunities, so there will be
mutual benefits and experience exchange between the two organizations.
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ANNEXES
Annex 1
1-Do you see ABR as a big problem
3-Are there any guidelines for infection control policies?
4-Who wrote the policy?
5-How is the implementation of guidelines of infection control implemented and monitored? E.g
hand hygiene?
6-How do you improve compliance of people?
7-Are there any guidelines on collecting and analyzing (surveillance) data of resistant strains?
8-Who coordinates ABR surveillance, (The microbiology lab or the infection control unit?
10- What information does the report contain and report to whom?
11-How much ABR surveillance reduce the ABR problem?
12- Which organisms pose the greatest problem? What information is the answer based on?
13-Do you have XDR or PDR pathogens reported?
13- How many infection control nurses and physicians you have, full time of part time?
14-What are the measures done for wards with higher infection rates to reduce the infection?
Politically with heads and physicians if not cooperate.
15- What do you see as the greatest drivers of ABR?
16-Is there an intranet to share data within the hospital? Do you share data outside the hospital?
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17-From your opinion what could be done to improve ABR?
1. In your experience, how are international AMR initiatives perceived by the Egyptians?
2. “Sustainability”, how can we reach it for AMR when international organisations stop
funding these programs?
3. How do you find the WHO global action plan to combat AMR?
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Annex 2
1. To start off, I would like to ask you to briefly describe your current role and the main
areas of your work?
2. Which organisations does WHO collaborate with to strengthen AMR surveillance in
Egypt?
3. What are the main challenges for strengthening AMR surveillance in Egypt?
4. In your experience, is the sharing of data problematic in Egypt? If so, what are the
greatest hurdles?
5. Does WHO have political support for AMR surveillance in Egypt? What convinces
policy makers to start surveillance on AMR?
6. What is the difference between the work of the US CDC on AMR surveillance in Egypt
and the work undertaken through WHO? Is there coordination between both
organizations?
7. In your experience, how are international AMR initiatives perceived by the Egyptian
government?
8. “Sustainability”, how can we reach it for AMR when international organisations stop
funding these programs?
9. There is a National Action Plan under way in Egypt. Do you know who is involved in
working on this Plan, and what the main priorities are?
10. How does WHO deal with the complicated health care structure in Egypt e.g hospitals are
under the umbrella of different ministries, and the role of private hospitals? Does WHO
consult and interact with all these different players in the healthcare system?
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Annex 3
1-Do you see Antimicrobial resistance (AMR) as a big problem at your hospital? What is the
percent?
2-Are there antibiotic policies you follow?
3-How do you find Infection control policies?
4-How do you find the WHO global action plan to combat AMR?
5-What are actions you take to prevent transmission of AMR?
6-What kinds of problems are you facing in your work which could hinder the application of
AMR GAP?
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Annex 4
1-Do you see Antimicrobial resistance (AMR) as a big problem at your hospital? What is the
percent?
2-Are there antibiotic policies you follow?
3-How do you find Infection control policies?
4-How do you find the WHO global action plan to combat AMR?
5-What are actions you take to prevent transmission of AMR?
6-What kinds of problems are you facing in your work which could hinder the application of
AMR GAP?
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Annex 5
1-Do you see Antimicrobial resistance (AMR) as a big problem at your hospital? What is the
percent?
2-Are there antibiotic policies you follow?
3-How do you find Infection control policies?
4-How do you find the WHO global action plan to combat AMR?
5-What are actions you take to prevent transmission of AMR?
6-What kinds of problems are you facing in your work which could hinder the application of
AMR GAP?
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Annex 6
1-Do you see ABR as a big problem
3-Are there any guidelines for infection control policies?
4-Who wrote the policy?
5-How is the implementation of guidelines of infection control implemented and monitored? E.g
hand hygiene?
6-How do you improve compliance of people?
7-Are there any guidelines on collecting and analyzing (surveillance) data of resistant strains?
When, why, type?
8-Who coordinates ABR surveillance, (The microbiology lab or the infection control unit?
10- What information does the report contain and report to whom?
11-How much ABR surveillance reduce the ABR problem?
12- Which organisms pose the greatest problem? What information is the answer based on?
13-Do you have XDR or PDR pathogens reported?
14-What are the measures done for wards with higher infection rates to reduce the infection?
15- What do you see as the greatest drivers of ABR?
16-Is there an intranet to share data within the hospital? Do you share data outside the hospital?
17-From your opinion what could be done to improve ABR?
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Annex 7
1-Do you see ABR as a big problem
3-Are there any guidelines for infection control policies?
4-Who wrote the policy?
5-How is the implementation of guidelines of infection control implemented and monitored? E.g
hand hygiene?
6-How do you improve compliance of people?
7-Are there any guidelines on collecting and analyzing (surveillance) data of resistant strains?
When, why, type?
8-Who coordinates ABR surveillance, (The microbiology lab or the infection control unit?
10- What information does the report contain and report to whom?
11-How much ABR surveillance reduce the ABR problem?
12- Which organisms pose the greatest problem? What information is the answer based on?
13-Do you have XDR or PDR pathogens reported?
14-What are the measures done for wards with higher infection rates to reduce the infection?
15- What do you see as the greatest drivers of ABR?
16-Is there an intranet to share data within the hospital? Do you share data outside the hospital?
17-From your opinion what could be done to improve ABR?
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Annex 8
1-Do you see ABR as a big problem?
2-Which organisms pose the greatest problem? What experiences, information is the answer
based on?
3-Is the lab going through a proficiency testing by external agency for sample analysis and
interpretation?
4- Do you contact the pharmacy to be sure that the drugs tested are available at the pharmacy?
5-How are the results recorded and reported to the ward?
6-Do you give a pre-analytical awareness for the nurses and physicians for sampling and
transport of samples?
7-How often do you consult a physician on managing a serious infection?
8-Do you notify physicians directly if you have MDR diagnosed?
9-Do you have XDR and PDR?
10-What are the wards show highest infection rates with MDR?
11-What do you see as the greatest drivers of ABR?
12-From your opinion what the lab could do to improve the ABR problem?
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Annex 9
1-Do you see ABR as a big problem?
2-Which organisms pose the greatest problem? What experiences, information is the answer
based on?
3-Is the lab going through a proficiency testing by external agency for sample analysis and
interpretation?
4- Do you contact the pharmacy to be sure that the drugs tested are available at the pharmacy?
5-How are the results recorded and reported to the ward?
6-Do you give a pre-analytical awareness for the nurses and physicians for sampling and
transport of samples?
7-How often do you consult a physician on managing a serious infection?
8-Do you notify physicians directly if you have MDR diagnosed?
9-Do you have XDR and PDR?
10-What are the wards show highest infection rates with MDR?
11-What do you see as the greatest drivers of ABR?
12-From your opinion what the lab could do to improve the ABR problem?
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Annex 10
1-Do you see ABR as a big problem?
2- Is there any guidelines regulate antibiotic use, prescription for treatment?
3-Who have the decisive role in controlling antibiotic usage,?
5-What do you see as the greatest drivers of ABR?
6-What aspects of prescribing practices may contribute to ABR?
7-Does the pharmacy report on the consumption of antibiotics?
8-Has application of ABR surveillance, infection control and antibiotic policy affected the
antibiotic consumption?
9-From your opinion what the pharmacy can do to improve the ABR problem (Dose, duration,
cycling)
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Annex 11
1-Do you see Antimicrobial resistance (AMR) as a big problem at your hospital? What is the
percent?
2-How do you find Infection control policies?
3-What are actions you take to prevent transmission of AMR?
4-What kinds of problems are you facing in your work which could hinder the application of
AMR GAP?
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